Michal Luntz, MD, is an Otologist, the director of the Ear and Hearing Center at A.R.M Otolaryngology-Head and Neck Surgery, Assuta MC, Tel Aviv. Her clinical practice and research focus on middle ear diseases, middle ear aeration, cochlear implantation, and hearing restoration solutions. She is one of the first (2001) cochlear implant surgeons who insisted on the importance of bimodal hearing and is responsible for establishing the Israeli criteria for cochlear implantation in adults (2006), allowing many individuals with moderate to profound hearing loss to be implanted early enough.
Michal graduated from Sackler School of Medicine (Tel Aviv University). After her residency, she divided her position between clinical work at the Department of Otolaryngology at Sheba MC and basic research at the Biomedical Engineering department at Tel Aviv University (aeration function of the middle ear and Eustachian tube). She then took a two-year fellowship in Otology, mentored by Tom Balkany and Fred Telischi at the University of Miami’s Ear Institute.
In 1997 she was appointed to chair the ENT department at Bnai Zion MC (Technion, the Israel Institute of Technology, 1997-2018). Between 2008-2019 she served as the Head of the ENT Department, Rappaport Faculty of Medicine, Technion. In 2018, she established the Ear and Hearing Center as part of A.R.M. Otolaryngology, in Assuta MC, Tel Aviv. Michal Luntz is an editorial board member in the Acta Otolaryngology, Laryngoscope, and Otology & Neurotology. In 2020 she was appointed as the president of the Israeli Society of Auditory research.
Michal Luntz experienced hearing deterioration during her fellowship in Oto-neurosurgery at the University of Miami Ear institute (1994-1996). She was then fitted with hearing aids. During her time as the Chairperson of the Department of Otolaryngology at Bnai Zion Medical Center she received cochlear implants sequentially (2003, 2011, University of Miami Ear Institute).